Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

85 results
Display

Treatment of Classic Kaposi's Sarcoma Showing a Discretely Scattered Distribution with Intralesional Vinblastine Injections

Kim BR, Park JT, Byun SY, Kwon SH, Huh CH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Palliative chemotherapy of soft tissue sarcoma with adriamycin and dacarbazine(ADIC) and cyclophosphamide, vinblastine, adriamycin and dacarbazine(CYVADIC)

Park YS, Kang WK, Suh CI, Kim HT, Kim HJ, Park KC, Heo DS, Bang YJ, Kim NK

  • KMID: 1742159
  • J Korean Cancer Assoc.
  • 1992 Jun;24(3):401-410.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Inappropriate ADH Secretion Secondary to Vinblastine Therapy

Park EH, Cho HS, Yoo HS, Lyu CJ, Yang CH, Kim KY

  • KMID: 2104416
  • J Korean Pediatr Soc.
  • 1998 Oct;41(10):1430-1432.
Inappropriate secretion of antidiuretic hormone (ADH) secondary to vincristine therapy has been reported frequently. But there has been five previous reports of vinblastine associated SIADH in the world and in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of combination therapy with vinblastine, adriamycin and interferon-alpha, gamma on human renal cell carcinoma cell lines

Lee ES, Kim HH, Ahn HJ, Min KJ, Lee C

  • KMID: 2060393
  • Korean J Urol.
  • 1992 Aug;33(4):611-617.
In vitro study was performed to evaluate the effect of combination therapy with vinblastine. adriamycin and interferon-alpha, gamma on human renal cell carcinoma cell lines. Three renal cell carcinoma cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Verapamil and Cyclosporin A on Cytotoxic Effect of Vinblastine upon Human Renal Cell Carcinoma Cell Lines

Kim HG, Kim HH, Lee C

  • KMID: 1913987
  • Korean J Urol.
  • 1995 Mar;36(3):231-240.
It is well known that renal cell carcinoma shows poor responses upon chemotherapy, and a multidrug-resistance has been suggested as one of the possible mechanisms of their resistances to chemotherapeutics...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Medroxyprogesterone Acetate On Cytotoxicity of Vinblastine in Renal Cell Carcinoma Cell Lines

Lee DH, Chung BH, Hong SJ

  • KMID: 1914473
  • Korean J Urol.
  • 1997 Jan;38(1):1-6.
Inadequate effectiveness of anticancer drug in treating renal cell carcinoma has been attributed to the overexpression of multidrug resistance gene (MDR1) and its product, membrane-bound P-glycoprotein. P-glycoprotein is known to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Testicular Embryonal Cell Carcinoma

Hun CK, Lee HS

Maligant testicular tumors in children are relatively rare and represent 1 percent of all malignant one in them. Since seventy per cent of pediatric testicular tumors are of germinal origin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination Chemotherapy to Hodgkin's Disease in a Pregnant Patient

Song EK, Kwak JY, Lee SO, Yim CY

  • KMID: 2143326
  • Korean J Hematol.
  • 2002 Nov;37(4):307-311.
Coincident Hodgkin's disease and pregnancy is rare and optimal management requires special consideration because usual treatment modalities are associated with significant risk to the developing fetus. We have experienced a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Advanced Hodgkin Lymphoma

Kim SY

  • KMID: 2264110
  • Korean J Med.
  • 2011 Nov;81(5):562-568.
The major portion of Hodgkin lymphoma (HL) patients, even at an advanced stage can be cured with optimal initial treatment. ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) is the standard treatment regimen...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Regimen on Experimental Animal: Histopathological Study

Kim SJ, Kim WJ, Kim YK

  • KMID: 2139584
  • Korean J Urol.
  • 1990 Feb;31(1):14-22.
Histopathologic study was performed to observe the effects of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin), widely used for advanced bladder cancer and its metastatic lesion, on the visceral organs of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Urothelial Tumors

Lee KS, Park CH, Lee SC

  • KMID: 2289517
  • Korean J Urol.
  • 1989 Jun;30(3):340-344.
Patients with advanced urothelial tumors that relapse or persist following conventional therapy have poor prognosis. Management of the patients with recurrent local or disseminated urothelial tumors presents a difficult clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Histiocytic Medullary Reticulosis in childhood Report of Three Cases

Chung KS, Kim KS, Yun DK, Kim PK, Kim KY, Kim BS, Kwon TJ, Chor IJ

  • KMID: 2142506
  • J Korean Pediatr Soc.
  • 1980 Oct;23(10):833-842.
Three cases of hisiocytic medullary reticulosis occurring in children aged 6 years, 9 years and 14 years, are described. In all children the diagnosis was based on anemia, granulocytopenia, thrombocytopenia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preliminary results of M-VAC(methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for advanced trasitional cell carcinoma of the urothelium

Jung SY, Kim SW, Yoon JY, Cho YH, Yoon MS, Lim SK

  • KMID: 1912838
  • Korean J Urol.
  • 1991 Feb;32(1):31-36.
We reviewed retrospectively 23 patients treated with M-VAC (Methotrexate. Vinblastine, Doxorubicin, Cisplatin) from October 1987 to June 1990 at our hospital to evaluate predictive variables for response to chemotherapy and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
M-VAC and MAC Combination Chemotherapy in Advanced Bladder Cancer

Kang HG, Chang JH

  • KMID: 1912868
  • Korean J Urol.
  • 1990 Dec;31(6):814-819.
Of the 11 advanced bladder cancer patients who received M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) combination chemotherapy, complete and partial remission were observed in 63.6%. Of the 17 advanced bladder...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of M-VAC (Methotrexate, vinblastine, Doxorubicin and cisplatin) Chemotherapy for Metastatic Transitional Cell Carcinoma of the bladder Preliminary Report

Lee KS, Paick JS, Lee C, Kim SW

  • KMID: 2289663
  • Korean J Urol.
  • 1990 Oct;31(5):648-654.
We treated 15 patients with metastatic transitional cell carcinoma with methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy. Median patient age was 58 years. The site of primary lesion was bladder...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatinum) Chemotherapy for Metastatic Transitional Cell Carcinoma

Sin CC, Chang SG, Kim JI

  • KMID: 2139365
  • Korean J Urol.
  • 1995 May;36(5):502-506.
We treated 23 patients with metastatic transitional cell carcinoma with methotrexate, vinblastine, doxorubicin and cisplatinum(M-VAC) chemotherapy from March 1989 to June 1994. The mean age of the patients was 60.0...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
M-VAC Monotherapy for Advanced Transitional Cell Carcinoma of the Bladder

Lee JZ, Yoon JB

  • KMID: 1912867
  • Korean J Urol.
  • 1990 Dec;31(6):807-813.
We retrospectively reviewed eleven patients with advanced bladder carcinoma (T3b-4) who were treated with methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy alone. 1. The mean age and the cycle were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neoadjuvant M-VAC (Methotrexate, Vinblastine, Adriamycin and Cisplatin) Effect on the Invasive Bladder Tumor

Oh JH, Ryu SB

  • KMID: 2290086
  • Korean J Urol.
  • 1996 Mar;37(3):293-300.
We evaluated the effect of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in 63 patients with invasive transitional cell carcinoma of the bladder between January 1987 and December 1993. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of GM-CSF to the M-VAC Chemotherapy Induced Leukopenia in Patients with Urothelial Cancer

Choi JB, Kim DS, Cho JH

  • KMID: 1913711
  • Korean J Urol.
  • 1994 Feb;35(2):151-155.
Granulocyte macrophage-colony stimulating factor (GM-CSF) occupies a central position in the regulation of hematopoietic responses. GM-CSF not only signals proliferations of granulocyte-macrophage but also drives these cells into differentiation and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy

Lee SY, Lee SR, Chang WJ, Kim HS, Kim BS, Kim IS

Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr